Antimicrobial Drug May Help Treat RCC

Share this content:

the Cancer Therapy Advisor take:

The already approved antimicrobial drug pentamidine may be effective in treating renal cell carcinoma (RCC), or kidney cancer, according to new research published in Molecular Cancer Therapeutics. The study, which matched RCC gene expression patterns from patients with gene expression changes produced by commonly used drugs, showed in animal models that pentamidine decreased tumor growth and improved survival. Because repurposing currently used drugs is less expensive and requires less time for development and testing, these results are important to the prompt discovery of a potential new treatment for RCC.

Antimicrobial Drug May Help Treat RCC
Antimicrobial Drug May Help Treat RCC
Developing and testing a new anti-cancer drug can cost billions of dollars and take many years of research. Finding an effective anti-cancer medication from the pool of drugs already approved for the treatment of other medical conditions could cut a considerable amount of time and money from the ...
READ FULL ARTICLE From Medical News Today

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs